Abnormal vaginal bleeding

Emergency Medicine

Volumn 15, Issue 3, 2003, Pages 215-218

  Bryan, Sheila ^a  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Menorrhagia; Uterine bleeding; Vaginal bleeding

Indexed keywords

ANTIFIBRINOLYTIC AGENT; FOLLITROPIN; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID;

ANOVULATION; ARTICLE; CURETTAGE; EMERGENCY WARD; ENDOMETRIUM CARCINOMA; FEMALE GENITAL TRACT INFECTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LEIOMYOMA; MENORRHAGIA; MENSTRUAL CYCLE; OVULATION; PRIORITY JOURNAL; UTERUS BLEEDING; UTERUS MYOMA; VAGINA BLEEDING;

EMERGENCY MEDICAL SERVICES; ENDOMETRIAL NEOPLASMS; ENDOMETRITIS; FEMALE; HUMANS; LEIOMYOMA; MENORRHAGIA; UTERINE HEMORRHAGE;

EID: 0038209838     PISSN: 10356851     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2026.2003.00461.x     Document Type: Article

References (19)

1. O'Brien S, Cameron I, MacLean A. Disorders of the Menstrual Cycle. London: RCOG Press, 2000.
2. Hickey M, Higham J, Fraser IS. Progestogens versus oestrogens for irregular uterine bleeding associated with anovulation. Cochrane Database Syst. Rev. 2002; 3.
3. Kadir RA, Economides DL, Sabin CA, Owens D, Lee C. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485-9.
4. Dockeray C, Sheppard B, Daly L, Bonner J. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid. Eur. J. Obstet. Gynecol. Reprod. Biol. 1987; 24: 309-18.
5. Smith S, Abel M, Kelly R, Baird D. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br. J. Obstet. Gynecol. 1981; 88: 434-42.
6. Lethaby A, Faquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst. Rev. 2002; 3.
7. Lethaby A, Augood C, Duckitt K. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst. Rev. 2002; 3.
8. Iyer V, Farquhar C, Jepson R. Oral contraceptive pills for heavy menstrual bleeding Cochrane Database Syst. Rev. 2002; 3.
9. Prentice A. Fortnightly review. Medical management of menorrhagia. BMJ 1999; 319: 1343-5.
10. Berntorp E, Follrud C, Lethagen S. No increased risk of venous thrombosis in women taking tranexamic acid. Thromb. Hemost. 2001; 86: 714-15.
11. Lethaby A, Irvine G, Cameron I. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst. Rev. 2002; 3.
12. Faquhar C, Lethaby A, Sowter M et al. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal bleeding. Am. J. Obstet. Gynecol. 1999; 181: 525-9.
13. Hickey M, Higham J, Fraser IS. Proestogens versus oestrogens and progestogens for irregular bleeding asssociated with anovulation. Cochrane Database Syst. Rev. 2002; 3.
14. Cramer S, Patel A. The frequency of uterine leiomyomas. Am. J. Clin. Pathol. 1990; 94: 435-8.
15. Stovall D. Clinical symptomatology of uterine leiomyomas. Clin. Obstetrics Gynecol. 2001; 44: 364-71.
16. Chavez N, Stewart E. Medical management of uterine fibroids. Clin. Obstet. Gynecol. 2001; 44: 372-84.
17. Peipert JF, Ness RB, Blume J et al. Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease. Am. J. Obstet. Gynecol. 2001; 184: 856-63.
18. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR, 2002; 51 (NoRR-6): 32-6, 69-71.
19. Fraser I, Petrucco OM. Management of intermenstrual and post coital bleeding and an appreciation of the issues arising out of the recent case of O'Shea versus Sullivan and Maquarie pathology. Aust. NZ J. O. G. 1996; 36: 67-71.